FY2027 EPS Estimate for SNC-Lavalin Group Boosted by Analyst

SNC-Lavalin Group Inc. (TSE:ATR) – Research analysts at Scotiabank lifted their FY2027 earnings per share (EPS) estimates for SNC-Lavalin Group in a report released on Wednesday, August 19th. Scotiabank analyst J. Goldman now forecasts that the company will earn $4.40 per share for the year, up from their previous estimate of $4.32.

SNC-Lavalin Group Price Performance

SNC-Lavalin Group Company Profile

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.